ABSTRACT
Governments globally face increasing pressure from climate advocates and international agreements, such as the Paris Agreement, to enact policies addressing climate change. This paper addresses the imperative for sustainable practices outlined in such agreements, with a specific focus on assessing the drivers of Green Procurement Practices (GPP) within Public Sector Organizations (PSOs). A dearth of research exists in systematically analyzing and prioritizing these drivers, exploring their interdependencies, and elucidating their relative importance. GPP is pivotal in market transformation by promoting environmentally friendly products and endorsing low-carbon, energy-efficient alternatives. This, in turn, contributes significantly to mitigating climate change and fostering a shift towards a greener, more sustainable economy. Identification of the drivers has been performed by an extensive review of the literature combined with the author's viewpoint, while the analysis has been performed using the novel method of Dominance-based Rough Set Approach (DRSA) and Interpretive Structural Modelling (ISM) with Matriced' Impacts Croise's Multiplication Applique'e a UN Classement (MICMAC) analysis. The study's outcome reveals that the Demand for Eco-friendly products is the primary driver for the incorporation of GPP, followed by the drivers' Presence of guidelines support and Government Regulations. Findings of the research also demonstrate that suppliers' propensity to adopt green practices depends on several factors, including sustainable supplier cooperation, degree of commitment to embrace green initiatives, government interventions in the form of incentives and guidelines support, and the presence of a legal framework. The findings of this research will enrich the understanding of policymakers and managers to formulate strategies for advancing GPP structured and sustainable implementation in PSOs. The study's findings will also benefit green technology sector advancement through the widespread adoption of GPP.
Subject(s)
Organizations , Public Sector , Government , Motivation , ParisABSTRACT
Background: The goal of the public procurement of pharmaceuticals is to purchase sufficient quantities of high-quality pharmaceuticals at cost-effective prices for a given population. This goal can be undercut if corruption infiltrates the procurement process. Good procurement practices can help mitigate the risks of corruption and support equitable access to affordable and high-quality medicines.Objectives: This paper aims to 1) examine manifestations of corruption in the pharmaceutical procurement process and key factors behind them, and 2) identify how to design and implement effective anti-corruption, transparency and accountability mechanisms within this process.Methods: This paper was informed by a narrative literature review from 1996 to the present. The search focused on publications that addressed the issue of pharmaceutical procurement and governance and corruption issues. Our search included peer-reviewed literature, books, grey literature such as working papers, reports published by international organizations and donor agencies, and some media articles. Some documents used in this paper were already known to the authors.Results: Procurement is highly vulnerable to corruption particularly in the health sector. What is more, corruption in the procurement process does not appear to be limited to any one level of government or type of health system. The better integration of accountability, transparency and anti-corruption mechanisms in the procurement process is needed to reduce the risk of corruption.Conclusions: Lessons learned suggest that anti-corruption, transparency and accountability mechanisms in the pharmaceutical procurement process, such as open contracting and integrity pacts are helpful towards reducing the risk of corruption.